This implies that despite the low total heritability explained by polymorphisms in these genes, monitoring genetic variations in BRCA1 and BRCA2 is advantageous for the diagnosis of breast cancer in high-risk patients [19]. The gene discussed is BRCA1; the disease is breast carcinoma.